Tanzawaic Acids, a Chemically Novel Set of Bacterial Conjugation Inhibitors
Bacterial conjugation is the main mechanism for the dissemination of multiple antibiotic resistance in human pathogens. This dissemination could be controlled by molecules that interfere with the conjugation process. A search for conjugation inhibitors among a collection of 1,632 natural compounds,...
Saved in:
Published in | PloS one Vol. 11; no. 1; p. e0148098 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
26.01.2016
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Bacterial conjugation is the main mechanism for the dissemination of multiple antibiotic resistance in human pathogens. This dissemination could be controlled by molecules that interfere with the conjugation process. A search for conjugation inhibitors among a collection of 1,632 natural compounds, identified tanzawaic acids A and B as best hits. They specially inhibited IncW and IncFII conjugative systems, including plasmids mobilized by them. Plasmids belonging to IncFI, IncI, IncL/M, IncX and IncH incompatibility groups were targeted to a lesser extent, whereas IncN and IncP plasmids were unaffected. Tanzawaic acids showed reduced toxicity in bacterial, fungal or human cells, when compared to synthetic conjugation inhibitors, opening the possibility of their deployment in complex environments, including natural settings relevant for antibiotic resistance dissemination. |
---|---|
Bibliography: | Competing Interests: Jose M. Sánchez-López, Marta Martínez and Antonio Fernández are employed by Biomar Microbial Technologies. Biomar Microbial Technologies and Fernando de la Cruz laboratory were collaborative partners of the grant 282004/FP7-HEALTH-2011-2.3.1-2 "Evolution and transfer of antibiotic resistance" financed by the European Seventh Framework Programme (https://ec.europa.eu/research/fp7). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: AF FdlC. Performed the experiments: MG RFL CPG JCG JMSL MM. Analyzed the data: MG RFL JCG FdlC. Wrote the paper: MG RFL FdlC. Current address: Department of Molecular Biology and Biochemistry, Drug Discovery Division, Southern Research Institute, Birmingham, Alabama, United States of America |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0148098 |